Arjuna therapeutics

Arjuna therapeutics

Developing an entirely novel class of orally available small molecules to address untreatable cancers. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€5—7m (Dealroom.co estimates Dec 2022.)
Company register number B70573209
A Coruña Galicia (HQ)
Authorizing premium user...